The National Adverse Event Following Immunisation committee has completed an in-depth case review of 498 serious and severe events, of which 26 cases have been reported to be potential thromboembolic.
The risk factor discovered by the committee in India is lower than the four cases per million found among those given Astrazeneca jabs in the UK.
This comes in the backdrop of some countries pausing AstraZeneca vaccine's rollout after deaths from intravascular clotting/thromboembolic events
However, it was confirmed that the two remaining deaths were not related to AEFI.
An ASHA worker, who was administered the second dose of Covid-19 vaccine two weeks ago, died of alleged Adverse Events Following Immunisation (AEFI) in the district.
This brings the cumulative serious AEFIs to 18 in the state, including 3 on Friday and total severe AEFIs to two, including one on the same day.
A death can be categorised an AEFI death only if the person dies within 30 minutes from the time he or she has taken the vaccine, it read.
Ever since the rollout of the vaccines a week ago, five deaths have been reported, but their AEFI reports tied them to comorbidities and not the vaccine.
The COVID-19 vaccination drive went off smoothly on Day 1 across Odisha barring three cases of minor adverse event following immunisation on Saturday.